未知股票 EXPR 深 沪
等待开盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 0.00
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 374.52万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 4.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Authentic Brands Group Has Expressed Interest In Buying Converse If It's Put Up For Sale- Bloomberg News
BRIEF-Authentic Brands Group Has Expressed Interest In Buying Converse If It's Put Up For Sale- Bloomberg News March 31 (Reuters) - AUTHENTIC BRANDS GROUP INC. HAS EXPRESSED INTEREST IN BUYING CONVERSE IF IT’S PUT UP FOR SALE- BLOOMBERG NEWS Source text: https://tinyurl.com/3cyukavk Further company
03-31 18:12
BRIEF-American Express Launches New Graphite Business Cash Unlimited Card
BRIEF-American Express Launches New Graphite Business Cash Unlimited Card March 25 (Reuters) - American Express Co AXP.N : AMERICAN EXPRESS: LAUNCHES NEW GRAPHITE BUSINESS CASH UNLIMITED CARD AMERICAN EXPRESS: BUSINESS MEMBERSHIP TO EXPAND WITH EIGHT NEW PRODUCTS, BENEFITS, AI-POWERED CAPABILITIES F
03-25 19:00
BRIEF-Muddy Waters Files Lawsuit Against Mota Engil In US Court For Defamation
BRIEF-Muddy Waters Files Lawsuit Against Mota Engil In US Court For Defamation March 16 (Reuters) - Mota Engil SGPS SA MOTA.LS : SAID ON SATURDAY, MUDDY WATER FILED CIVIL LAWSUIT IN UNITED STATES' COURT TO HOLD CEO AND MOTA ENGIL LIABLE FOR DEFAMATION DEFAMATION BASED ON STATEMENT IN WHICH MUDDY WAT
03-16 14:30
BRIEF-Novonix Expresses Disappointment With Final Determination Of U.S. International Trade Commission
BRIEF-Novonix Expresses Disappointment With Final Determination Of U.S. International Trade Commission March 13 (Reuters) - Novonix Ltd NVX.AX : EXPRESSED DISAPPOINTMENT WITH FINAL DETERMINATION OF U.S. INTERNATIONAL TRADE COMMISSION Further company coverage: NVX.AX (( Reuters.Briefs@thomsonreuters.
03-13 08:57
Middle East flights halted after US-Israel strike on Iran
Middle East flights halted after US-Israel strike on Iran Adds Air Canada, Pegasus Airlines, updates first two paragraphs and Qatar Airways, Flydubai, IndiGo, Air India entries March 1 (Reuters) - Airlines kept cancelling flights across the Middle East on Sunday, as much of the region’s airspace rem
03-01 15:44
BRIEF-Berkshire Hathaway Reported $373.3 Billion Of Cash And Equivalents As Of December 31, 2025
BRIEF-Berkshire Hathaway Reported $373.3 Billion Of Cash And Equivalents As Of December 31, 2025 Feb 28 (Reuters) - BERKSHIRE HATHAWAY: REPORTED $373.3 BILLION OF CASH AND EQUIVALENTS AS OF DECEMBER 31, 2025 BERKSHIRE HATHAWAY: AT DECEMBER 31, 2025, APPROX 65% OF AGGREGATE FAIR VALUE OF OUR INVESTME
02-28 21:40
BRIEF-American Express To Build New State-Of-The-Art Global Headquarters At 2 World Trade Center
BRIEF-American Express To Build New State-Of-The-Art Global Headquarters At 2 World Trade Center Feb 25 (Reuters) - American Express Co AXP.N : AMERICAN EXPRESS TO BUILD NEW STATE-OF-THE-ART GLOBAL HEADQUARTERS AT 2 WORLD TRADE CENTER, DEEPENING COMMITMENT TO LOWER MANHATTAN AMERICAN EXPRESS CO - DE
02-25 22:08
BRIEF-American Express Says USCS Card Member Loans 30 Days Past Due Loans As A% Of Total 1.4% At Jan 2026 End
BRIEF-American Express Says USCS Card Member Loans 30 Days Past Due Loans As A% Of Total 1.4% At Jan 2026 End Feb 17 (Reuters) - American Express Co AXP.N : AMERICAN EXPRESS- USCS CARD MEMBER LOANS 30 DAYS PAST DUE LOANS AS A % OF TOTAL 1.4 % AT JAN 2026 END AMERICAN EXPRESS- U.S. SMALL BUSINESS CAR
02-18 01:12
BRIEF-Nba And American Express Announce Multiyear Partnership Extension
BRIEF-Nba And American Express Announce Multiyear Partnership Extension Feb 10 (Reuters) - American Express Co AXP.N : NBA AND AMERICAN EXPRESS ANNOUNCE MULTIYEAR PARTNERSHIP EXTENSION AMERICAN EXPRESS CO - DEAL ADDS USA BASKETBALL AND NBA TAKE-TWO MEDIA TO AMEX PORTFOLIO Source text: ID:nBw1b3TlKa
02-10 23:18
BRIEF-GT Biopharma Gets FDA IND Clearance For GTB-5550 TRiKE, B7-H3-Targeted NK Engager For B7-H3+ Solid Tumors
BRIEF-GT Biopharma Gets FDA IND Clearance For GTB-5550 TRiKE, B7-H3-Targeted NK Engager For B7-H3+ Solid Tumors Feb 3 (Reuters) - GT Biopharma Inc GTBP.O : GT BIOPHARMA ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR GTB-5550 TRIKE®, A B7-H3-TARGETED NATURAL KILLER (NK) CEL
02-03 21:47
